The purpose of HTA is to provide high-quality information to decision makers about the clinical effectiveness, cost-effectiveness, and broader impact of drugs, medical technologies, and health systems.
In the EU, rare diseases that are also life-threatening or chronically debilitating with a low pr
Uncertainty in economic evaluation of innovative therapies is often managed by a call for more ev
Healthcare biotechnology refers to a medicinal or diagnostic product or a vaccine that consists o
It is estimated that over 6,000 rare diseases exist, although some say the actual number is close
Both patients and the public have to be regularly informed about what the use and procedures of H